Disease Models

KCI has established an anti-infective R&D and service platform with both BSL2 and ABSL2 qualifications. The BSL-2 laboratory covers an area of about 200m², including cells, viruses, and bacteria, while the ABSL2 laboratory covers an area of about 1,000m², with a small animal laboratory of 300m² and a large animal laboratory of 700m². After nearly 2 years of internal research and development and external services, this platform has completed the filing of more than 70 kinds of pathogenic microorganisms, successfully established more than 20 kinds of viral and bacterial fungal infectious animal models, and has cooperated with more than 20 new drug research and development enterprises in the fields of human vaccines and anti-infectious drugs, veterinary vaccines and anti-infectious drugs, etc, which help preclinical drug development and filing.